Pharvaris Other Operating Expenses vs Net Income From Continuing Ops Analysis
PHVS Stock | USD 22.36 1.81 7.49% |
Pharvaris financial indicator trend analysis is much more than just breaking down Pharvaris BV prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pharvaris BV is a good investment. Please check the relationship between Pharvaris Other Operating Expenses and its Net Income From Continuing Ops accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharvaris BV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Other Operating Expenses vs Net Income From Continuing Ops
Other Operating Expenses vs Net Income From Continuing Ops Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pharvaris BV Other Operating Expenses account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have pay attention.
The correlation between Pharvaris' Other Operating Expenses and Net Income From Continuing Ops is -0.93. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Pharvaris BV, assuming nothing else is changed. The correlation between historical values of Pharvaris' Other Operating Expenses and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Pharvaris BV are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Other Operating Expenses i.e., Pharvaris' Other Operating Expenses and Net Income From Continuing Ops go up and down completely randomly.
Correlation Coefficient | -0.93 |
Relationship Direction | Negative |
Relationship Strength | Significant |
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Pharvaris BV. It is also known as Pharvaris overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Net Income From Continuing Ops
Most indicators from Pharvaris' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pharvaris BV current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharvaris BV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. At this time, Pharvaris' Tax Provision is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 66 M in 2024, whereas Selling General Administrative is likely to drop slightly above 16 M in 2024.
Pharvaris fundamental ratios Correlations
Click cells to compare fundamentals
Pharvaris Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pharvaris fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 20.6M | 101.1M | 212.1M | 167.7M | 398.7M | 418.6M | |
Other Current Liab | 1.4M | 4.5M | (2.5M) | 10.9M | 11.1M | 11.6M | |
Total Current Liabilities | 1.9M | 5.3M | 7.0M | 18.2M | 14.6M | 7.5M | |
Total Stockholder Equity | 18.7M | 95.8M | 205.0M | 149.3M | 384.0M | 403.3M | |
Net Debt | (20.3M) | (98.6M) | (209.1M) | (161.4M) | (391.0M) | (371.4M) | |
Retained Earnings | (18.5M) | (44.5M) | (87.6M) | (164.2M) | (265.9M) | (252.6M) | |
Accounts Payable | 509.9K | 656.4K | 2.1M | 6.0M | 2.9M | 2.0M | |
Cash | 20.3M | 98.6M | 209.4M | 161.8M | 391.2M | 410.8M | |
Non Current Assets Total | 12.9K | 147.8K | 523.4K | 886.2K | 843.1K | 885.3K | |
Cash And Short Term Investments | 20.3M | 98.6M | 209.4M | 161.8M | 391.2M | 410.8M | |
Net Receivables | 210.8K | 569.6K | 700.1K | 382.5K | 1.0M | 1.1M | |
Liabilities And Stockholders Equity | 20.6M | 101.1M | 212.1M | 167.7M | 398.7M | 418.6M | |
Non Current Liabilities Total | 509.9K | 847.0K | 150.8K | 249.4K | 43.6K | 41.4K | |
Other Stockholder Equity | 36.5M | 138.0M | 278.7M | 289.2M | 615.8M | 646.6M | |
Total Liab | 1.9M | 5.3M | 7.1M | 18.5M | 14.6M | 7.6M | |
Net Invested Capital | 18.7M | 95.8M | 205.0M | 149.3M | 384.0M | 403.3M | |
Total Current Assets | 20.6M | 101.0M | 211.6M | 166.8M | 397.9M | 417.7M | |
Accumulated Other Comprehensive Income | 392.1K | 2.0M | 9.8M | 20.2M | 27.9M | 29.3M | |
Net Working Capital | 18.7M | 95.6M | 204.6M | 148.6M | 383.2M | 402.4M | |
Common Stock | 131.0K | 235.7K | 4.0M | 4.1M | 6.3M | 6.6M | |
Net Tangible Assets | 18.6M | 95.6M | 205.0M | 149.3M | 171.6M | 104.1M | |
Other Current Assets | 47.5K | 1.8M | 1.5M | 4.6M | 5.6M | 5.9M | |
Capital Stock | 131.0K | 235.7K | 4.0M | 4.1M | 6.3M | 6.6M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pharvaris Stock Analysis
When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.